Institute of Public Health and Clinical Nutrition.
Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy.
Am J Clin Nutr. 2018 Nov 1;108(5):971-979. doi: 10.1093/ajcn/nqy169.
Epidemiologic evidence suggests that diets rich in whole grains are associated with a reduced risk of developing chronic diseases and all-cause mortality. However, the molecular mechanisms behind these beneficial metabolic effects are poorly understood.
Our aim was to investigate novel trimethylated (betainized) compounds from mice and humans, and their association with whole grain-rich diets and insulin resistance and insulin secretion.
Fasting plasma samples were obtained in a mouse (C57BL/6J male) feeding trial and a controlled dietary intervention. The mouse trial involved feeding the mice a rye and wheat bran-enriched feed which was compared with a high-fat diet. In the human trial, participants recruited from Kuopio, Finland (n = 69) and Naples, Italy (n = 54) with characteristics of the metabolic syndrome were randomly assigned to either a whole grain-enriched diet or a control diet for 12 wk. Plasma concentrations of betainized compounds were analyzed with the use of liquid chromatography-tandem mass spectrometry. Insulin resistance and insulin secretion were assessed in an oral-glucose-tolerance test and a meal-glucose-tolerance test.
The betaines that were increased in mouse plasma after bran-enriched feeding were identified de novo via chemical synthesis and liquid chromatography-tandem mass spectrometry, and confirmed to be associated with an increased intake of whole-grain products in humans. In particular, the concentrations of pipecolic acid betaine were increased at the end of the whole-grain intervention in both the Kuopio cohort (P < 0.001) and the Naples cohort (P < 0.05), and these concentrations inversely correlated with the postprandial glucose concentration. Furthermore, the concentration of valine betaine was substantially increased during the intervention in Naples (P < 0.001) with an inverse correlation with the postprandial insulin concentration. In addition, the concentrations of other betaines, e.g., glycine betaine and proline betaine, correlated with glucose and insulin concentrations at the end of the intervention.
Novel betainized compounds in humans are associated with diets rich in whole grains, and they improve insulin resistance and insulin secretion. These results suggest that these novel compounds may contribute to the beneficial effects of whole grain-rich diets. The studies were registered at clinicaltrials.gov as NCT00945854 (Naples) and NCT00573781 (Kuopio).
流行病学证据表明,富含全谷物的饮食与降低慢性病和全因死亡率的风险有关。然而,这些有益的代谢效应背后的分子机制还知之甚少。
我们的目的是研究来自小鼠和人类的新型三甲基(甜菜碱化)化合物,以及它们与富含全谷物的饮食和胰岛素抵抗、胰岛素分泌的关系。
在一项小鼠(C57BL/6J 雄性)喂养试验和一项对照饮食干预中,采集禁食血浆样本。在小鼠试验中,用富含黑麦和麦麸的饲料喂养小鼠,与高脂肪饮食进行比较。在人类试验中,从芬兰的库奥皮奥(n=69)和意大利的那不勒斯(n=54)招募具有代谢综合征特征的参与者,随机分配到富含全谷物的饮食或对照饮食 12 周。使用液相色谱-串联质谱法分析甜菜碱化化合物的血浆浓度。在口服葡萄糖耐量试验和餐食葡萄糖耐量试验中评估胰岛素抵抗和胰岛素分泌。
在用富含麸皮的饲料喂养后,在小鼠血浆中增加的甜菜碱通过化学合成和液相色谱-串联质谱法被首次鉴定出来,并通过液相色谱-串联质谱法在人类中得到确认,与全谷物产品摄入量的增加有关。特别是,在整个谷物干预结束时,在库奥皮奥队列中(P<0.001)和那不勒斯队列中(P<0.05),哌可酸甜菜碱的浓度均增加,并且这些浓度与餐后血糖浓度呈负相关。此外,在那不勒斯的干预过程中,缬氨酸甜菜碱的浓度大幅增加(P<0.001),与餐后胰岛素浓度呈负相关。此外,其他甜菜碱,如甘氨酸甜菜碱和脯氨酸甜菜碱的浓度与干预结束时的血糖和胰岛素浓度相关。
人类中的新型甜菜碱化化合物与富含全谷物的饮食有关,可改善胰岛素抵抗和胰岛素分泌。这些结果表明,这些新型化合物可能有助于全谷物丰富饮食的有益效果。这些研究在 clinicaltrials.gov 上注册为 NCT00945854(那不勒斯)和 NCT00573781(库奥皮奥)。